How ageing harms the body’s response to raging infection - Nature
Google News • 1/14/2026 – 1/16/2026
Summary
The article from Nature discusses how ageing negatively impacts the body's response to severe infections. It explores age-related tradeoffs in disease tolerance and infection pathogenesis in mice. Additionally, the Salk Institute for Biological Studies raises the question of whether younger and older individuals should receive different treatments for the same infection. BIOENGINEER.ORG also addresses age-related tradeoffs in mouse disease tolerance.
Advertisement
Lindy Score Breakdown (V4.2)
94d
Age
1
Sources
from cluster
2218
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^2218/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^2218/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (6/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 94 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: Don’t believe headlines saying that vaccine skepticism is widespread
Stat News • 1 day ago
How Trump is pushing psychedelics reform through the health agencies
Stat News • Today
Opinion: The podcast bringing together MAHA and public health for hard conversations
Stat News • Today
Opinion: Health care is not ready for the new era of AI-enabled cyberattacks
Stat News • 1 day ago
Trump taps former public health leader Erica Schwartz to run CDC
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Stat News • 1 day ago
STAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more
Stat News • 2 days ago
STAT+: Roche to launch another Elevidys trial, with eyes on European approval
Stat News • 2 days ago
STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
Stat News • 2 days ago